SEC Form 4 · accession 0001144204-18-014486
INNOVATE BIOPHARMACEUTICALS, INC. · INNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David H Clarke
Officer — Former CEO and Director · Director
Period of report
Jul 13, 2016
Accepted (ET)
Mar 13, 2018 · 10:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551986
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 13, 2016 | P | 15,000 | $4.50 | A | 445,043 | D | |
| Common StockF1 | Jan 24, 2017 | A | 175,000 | $0.00 | A | 620,043 | D | |
| Common StockF2 | Mar 16, 2017 | P | 70,000 | $1.50 | A | 690,043 | I | See footnote |
| Common StockF2 | Jun 23, 2017 | P | 172,414 | $0.58 | A | 862,457 | I | See footnote |
| Common StockF2 | Jun 30, 2017 | A | 33,621 | $0.00 | A | 896,078 | I | See footnote |
| Common StockF2 | Jun 30, 2017 | A | 13,467 | $0.00 | A | 909,545 | I | See footnote |
| Common Stock | Nov 9, 2017 | A | 100,000 | $0.00 | A | 1,009,545 | D | |
| Common StockF2 | Nov 29, 2017 | P | 366,159 | $0.45 | A | 1,375,704 | I | See footnote |
| Common StockF2 | Jan 24, 2018 | A | 17,746 | $0.00 | A | 1,393,450 | I | See footnote |
| Common StockF1 | Jan 25, 2018 | A | 25,000 | $0.00 | A | 1,418,450 | D | |
| Common StockF2 | Jan 26, 2018 | P | 300,000 | $0.35 | A | 1,718,450 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of restricted common stock granted under Issuer's 2012 Omnibus Incentive Plan.
- F2Reporting Person's beneficial ownership includes: 71,402 shares of common stock held by his spouse and 1,063,350 shares of common stock held by GSB Holdings, Inc., a corporation owned by his spouse and children.